Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04478266 |
|---|---|
| Brief Title: | Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer (AMEERA-5) |
| First Submitted : | July 10, 2020 |
| First Submitted that Met QC Criteria : | July 15, 2020 |
| First Posted : | July 20, 2020 |
| Results First Submitted : | June 13, 2023 |
| Results First Submitted that Met QC Criteria : | June 13, 2023 |
| Results First Posted : | July 6, 2023 |
| Last Update Submitted that Met QC Criteria : | November 15, 2023 |
| Last Update Posted : | December 8, 2023 |